Recap: Hyperfine Q1 Earnings

Hyperfine (NASDAQ:HYPR) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:05 PM. Here’s what investors…

Hyperfine (NASDAQ:HYPR) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Hyperfine missed estimated earnings by 30.77%, reporting an EPS of $-0.17 versus an estimate of $-0.13.

Revenue was up $1.13 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 9.68% drop in the share price the next day.

Here’s a look at Hyperfine’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.22 -0.26 -0.27 -0.21
EPS Actual -0.19 -0.19 -0.33 -0.34
Revenue Estimate 2.25M 1.55M 1.70M 1.00M
Revenue Actual 1.42M 2.35M 1.53M 1.51M

To track all earnings releases for Hyperfine visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Apple Avoids Layoffs, Dogecoin Surges, South America Does A Eurozone And More: 5 Key Stories You May Have Missed From The Weekend

As the fourth-quarter reporting season starts in earnest this week, chatter over the weekend focused on its impact on the fledgling recovery seen in the market. Discussions also centered around the odds of a recession materializing and the likely monetary policy stance of the Federal Reserve when it meets at the end of the month.

$DOGE

Read More

Earnings Outlook For Theriva Biologics

Theriva Biologics (AMEX:TOVX) is set to give its latest quarterly earnings report on Friday, 2022-11-11. Here's what investors need to know before the announcement. Analysts estimate that Theriva Biologics will report an earnings per share (EPS) of $-0.39.

TOVX

Read More

Jaguar Health’s Earnings: A Preview

Jaguar Health (NASDAQ:JAGX) is set to give its latest quarterly earnings report on Monday, 2022-08-22. Here's what investors need to know before the announcement. Analysts estimate that Jaguar Health will report an earnings per share (EPS) of $-0.22.

JAGX